Article
SIRT6 promotes metastasis and relapse in HER2-positive breast cancer
12 Dec 2023
Abstract excerpt
The histone deacetylase sirtuin 6 (SIRT6) has been endowed with anti-cancer capabilities in many tumor types. Here, we investigate the impact of SIRT6-overexpression (SIRT6-OE) in Delta16HER2 mice, which are a bona fide model of HER2-positive breast cancer. After an initial delay in the tumor onset, SIRT6-OE induces a more aggressive phenotype of Delta16HER2 tumors promoting the formation of higher number of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
